Lipocine Dividend
Dividend criteria checks 0/6
Lipocine does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0 |
| Earnings per share | -US$0.12 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Lipocine announces plans to focus on treating CNS disorders, shares rise ~5%
Sep 26Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?
Feb 22
Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?
Sep 14Lipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depression
Jun 14Lipocine competitor prevails in patent infringement lawsuit for Jatenzo
May 26When Will Lipocine Inc. (NASDAQ:LPCN) Turn A Profit?
May 11Lipocine EPS beats by $0.01
May 06Lipocine Inc. (NASDAQ:LPCN): Are Analysts Optimistic?
Jan 26Lipocine announces positive results from phase 2biopsy-confirmed NASH study
Jan 12FDA Ok's Lipocine's testosterone replacement therapy, tentatively
Dec 09Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?
Dec 04
Lipocine EPS misses by $0.01
Nov 10Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection
Nov 06Stability and Growth of Payments
| Month | Dividend Per Share (annual) | Avg. Yield (%) |
|---|
Dividend Yield vs Market
| Lipocine Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LPCN) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Pharmaceuticals) | 2.7% |
| Analyst forecast in 3 Years (LPCN) | n/a |